Bayer US Pharmaceuticals’ Sebastian Guth: Designs On A New Decade

Cancer, Cardio And Culture Are Top Of Mind Targets For Tomorrow’s Top Line Growth

Jan 02 2020

• By William Looney

Sebastian Guth, Bayer Pharmaceuticals' President For The Americas

More from Outlook Archive

More from Outlook